About [6-[1-hydroxy-3-methyl-1-(1-tritylimidazol-4-yl)butyl]naphthalen-2-yl] trifluoromethanesulfonate;isocyanic acid
[6-[1-hydroxy-3-methyl-1-(1-tritylimidazol-4-yl)butyl]naphthalen-2-yl] trifluoromethanesulfonate;isocyanic acid (PubChem CID 162621363) has the molecular formula C40H35F3N4O6S
and a molecular weight of 756.80 g/mol. Its IUPAC name is [6-[1-hydroxy-3-methyl-1-(1-tritylimidazol-4-yl)butyl]naphthalen-2-yl] trifluoromethanesulfonate;isocyanic acid.
Molecular Properties
| Compound Name | [6-[1-hydroxy-3-methyl-1-(1-tritylimidazol-4-yl)butyl]naphthalen-2-yl] trifluoromethanesulfonate;isocyanic acid |
| PubChem CID | 162621363 |
| Molecular Formula | C40H35F3N4O6S |
| Molecular Weight | 756.80 g/mol |
| Exact Mass | 756.22 |
| IUPAC Name | [6-[1-hydroxy-3-methyl-1-(1-tritylimidazol-4-yl)butyl]naphthalen-2-yl] trifluoromethanesulfonate;isocyanic acid |
| SMILES | CC(C)CC(O)(c1ccc2cc(OS(=O)(=O)C(F)(F)F)ccc2c1)c1cn(C(c2ccccc2)(c2ccccc2)c2ccccc2)cn1.N=C=O.N=C=O |
| InChI | InChI=1S/C38H33F3N2O4S.2CHNO/c1-27(2)24-36(44,33-20-18-29-23-34(21-19-28(29)22-33)47-48(45,46)38(39,40)41)35-25-43(26-42-35)37(30-12-6-3-7-13-30,31-14-8-4-9-15-31)32-16-10-5-11-17-32;2*2-1-3/h3-23,25-27,44H,24H2,1-2H3;2*2H |
| InChIKey | PAIVPTLTTVHKNQ-UHFFFAOYSA-N |
| XLogP | 8.19 |
| TPSA | 163.26 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 54 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 756.80 |
| LogP ≤ 5 | 8.19 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 10 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'isocyanate', 'substructure': 'N/A'}, {'alert_name': 'Sulfonic_acid_1', 'substructure': 'N/A'}, {'alert_name': 'triflate', 'substructure': 'N/A'}, {'alert_name': 'triphenyl_methyl-silyl', 'substructure': 'N/A'} |
|---|
Analyze [6-[1-hydroxy-3-methyl-1-(1-tritylimidazol-4-yl)butyl]naphthalen-2-yl] trifluoromethanesulfonate;isocyanic acid with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of [6-[1-hydroxy-3-methyl-1-(1-tritylimidazol-4-yl)butyl]naphthalen-2-yl] trifluoromethanesulfonate;isocyanic acid?
The IUPAC name of [6-[1-hydroxy-3-methyl-1-(1-tritylimidazol-4-yl)butyl]naphthalen-2-yl] trifluoromethanesulfonate;isocyanic acid (CID 162621363) is [6-[1-hydroxy-3-methyl-1-(1-tritylimidazol-4-yl)butyl]naphthalen-2-yl] trifluoromethanesulfonate;isocyanic acid.
What is the SMILES notation for [6-[1-hydroxy-3-methyl-1-(1-tritylimidazol-4-yl)butyl]naphthalen-2-yl] trifluoromethanesulfonate;isocyanic acid?
The canonical SMILES for [6-[1-hydroxy-3-methyl-1-(1-tritylimidazol-4-yl)butyl]naphthalen-2-yl] trifluoromethanesulfonate;isocyanic acid is CC(C)CC(O)(c1ccc2cc(OS(=O)(=O)C(F)(F)F)ccc2c1)c1cn(C(c2ccccc2)(c2ccccc2)c2ccccc2)cn1.N=C=O.N=C=O.
What is the InChIKey of [6-[1-hydroxy-3-methyl-1-(1-tritylimidazol-4-yl)butyl]naphthalen-2-yl] trifluoromethanesulfonate;isocyanic acid?
The InChIKey is PAIVPTLTTVHKNQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C38H33F3N2O4S.2CHNO/c1-27(2)24-36(44,33-20-18-29-23-34(21-19-28(29)22-33)47-48(45,46)38(39,40)41)35-25-43(26-42-35)37(30-12-6-3-7-13-30,31-14-8-4-9-15-31)32-16-10-5-11-17-32;2*2-1-3/h3-23,25-27,44H,24H2,1-2H3;2*2H.
What are the key properties of [6-[1-hydroxy-3-methyl-1-(1-tritylimidazol-4-yl)butyl]naphthalen-2-yl] trifluoromethanesulfonate;isocyanic acid?
[6-[1-hydroxy-3-methyl-1-(1-tritylimidazol-4-yl)butyl]naphthalen-2-yl] trifluoromethanesulfonate;isocyanic acid has a molecular weight of 756.80 g/mol, XLogP of 8.19, 10 rotatable bonds, 3 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for [6-[1-hydroxy-3-methyl-1-(1-tritylimidazol-4-yl)butyl]naphthalen-2-yl] trifluoromethanesulfonate;isocyanic acid is sourced from PubChem (CID 162621363), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).